๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Clinical Study of rhTPO in Hematopoietic Stem Cell Mobilization for Autologous Transplantation in Acute Leukemia
NCT06955858Hematopoietic Stem Cell Mobilization
Institute of Hematology & Blood Diseases Hospital, China
Not applicable
60
Tianjin
2025-05-30
Not yet open
A Phase Ib Study of HS-10370 in Addition to Other Anti-cancer Therapies in Patients With Advanced Solid Tumors
NCT06963502Advanced Solid Tumors, Colorectal Cancer, Non-Small Cell Lung Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Phase 1
762
Hangzhou, Shanghai
2025-05-30
Not yet open
Arthroscopic Treatment of Rotator Cuff Tears
NCT06961318Rotator Cuff
Peking University Third Hospital
Observational
600
Beijing
2025-05-30
Recruiting
Multimodal Imaging and Digital Pathology for Prostate Cancer Prediction
NCT07614256Prostate Cancer (Diagnosis), Clinically Significant Prostate Cancer
Guangxi Medical University
Observational
3,000
Liuzhou
2025-05-30
Recruiting
The Clinical Study on the Treatment of Refractory RA With UTAA91 Injection
NCT07001956Rheumatoid Arthritis (RA)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase EARLY_PHASE1
24
Wuhan
2025-05-30
Recruiting
Assessment of Transcranial Alternating Current Stimulation's Clinical Efficacy in Treating Cognitive Impairment of Idiopathic Inflammatory Demyelinating Diseases
NCT07087873Idiopathic Inflammatory Demyelinating Disorders of the Central Nervous System, MS (Multiple Sclerosis), NMOSD, Acute Disseminated Encephalomyelitis
Xuanwu Hospital, Beijing
Not applicable
128
Beijing
2025-05-30
Not yet open
Glofitamab for Consolidation After First-line Treatment of High-risk Large B-cell Lymphoma
NCT06956092B Cell Lymphoma (BCL)
Zhengzhou University
Phase 4
40
Zhengzhou
2025-05-30
Recruiting
JY231(JY231) Injection for the Treatment of Relapsed/Refractory B Cell Lymphoma/ Leukemia
NCT06940960B Acute Lymphoblastic Leukemia, B-Non Hodgkin Lymphoma
Affiliated Hospital of Guangdong Medical University
Not applicable
20
Guangzhou
2025-05-30
Not yet open
hucMSCs Exosomes for the Treatment of Active Ulcerative Colitis
NCT06853522Ulcerative Colitis (UC)
Shanghai East Hospital
Phase EARLY_PHASE1
40
Shanghai
2025-05-30
Recruiting
XP-005 Personalized Vaccine Alone or in Combination With Toripalimab for the Prevention of Relapse After Remission in Acute Myeloid Leukemia
NCT06980155Acute Myeloid Leukemia
Shanghai Jiao Tong University School of Medicine
Phase EARLY_PHASE1
60
Shanghai
2025-05-30
Recruiting
A Study of HDM2005 in Patients With Advanced Solid Tumor
NCT07004296Advanced Solid Tumors
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Phase 1
72
Shanghai
2025-05-29
Active, closed
Transcranial Direct Current Stimulation for Cancer-related Cognitive Impairment in Breast Cancer Survivors
NCT07083518Transcranial Direct Current Stimulation (tDCS), Breast Cancer Survivor, Cognitive Impairment
Anhui Medical University
Not applicable
60
Hefei
2025-05-29
Recruiting
Recombinant Human IL-21-expressing Oncolytic Vaccinia Virus Injection (hV01) in Advanced Pancreatic Cancer
NCT07006077Advanced Pancreatic Cancer
Hangzhou Converd Co., Ltd.
Phase 2
12
Hangzhou
2025-05-29
Active, closed
A Study of BGB-16673 Compared to Investigator's Choice in Participants With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Covalent Bruton Tyrosine Kinase (BTK) Inhibitors
NCT06970743Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
BeOne Medicines
Phase 3
153
Hefei, Beijing, Chongqing, Fuzhou, Guangzhou, Meizhou, Shenzhen, Nanning
2025-05-29
Recruiting
Investigation of Pharmacokinetics,Safety,and Pharmacodynamics of HSK39297 in Subjects With Hepatic Impairment
NCT07152288Paroxysmal Nocturnal Hemoglobinuria (PNH)
Haisco Pharmaceutical Group Co., Ltd.
Phase 1
24
Beijing
2025-05-29
Recruiting
Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T Cells in Patients With Advanced Sarcomas
NCT07066982Sarcoma, Sarcoma, Kaposi, Sarcoma, Ewing, Sarcoma,Soft Tissue
Essen Biotech
Phase 1/2
60
Beijing
2025-05-29
Recruiting
Stellate Ganglion Morphine Infiltration on Myocardial Ischemia-Reperfusion Injury
NCT06947135Acute Myocardial Infarction
The Second Hospital of Anhui Medical University
Not applicable
166
Hefei, Changsha
2025-05-29
Recruiting
A Phase I Study of HS-20108 in Participants With Advanced Solid Tumors
NCT06936735Advanced Solid Tumor
Hansoh BioMedical R&D Company
Phase 1
502
Shanghai
2025-05-29
Recruiting
Evaluation of GM101 Injection in Patients With Parkinson's Disease
NCT07100171Parkinson's Disease
Genemagic Biosciences Co., Ltd
Phase EARLY_PHASE1
10
Changsha
2025-05-29
Recruiting
JS207 Combined With JS007 as First-line Treatment for Advanced Hepatocellular Carcinoma
NCT06954467Hepatocellular Carcinoma
Shanghai Junshi Bioscience Co., Ltd.
Phase 2
72
Hefei, Beijing, Harbin, Zhengzhou, Changsha, Nanchang, Shenyang, Shanghai
2025-05-29
Recruiting
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
NCT06764615Crohn's Disease, Ulcerative Colitis
Takeda
Phase 2
192
Chongqing, Guangdong, Guangzhou, Shanghai
2025-05-28
Active, closed
Study of BLU-808 in Chronic Inducible Urticaria (CIndU) and Chronic Spontaneous Urticaria (CSU)
NCT06931405Chronic Inducible Urticaria, Chronic Spontaneous Urticaria
Blueprint Medicines Corporation
Phase 2
105
2025-05-28
Recruiting
A Study to Assess the Efficacy and Safety of Firmonertinib Versus Placebo for Adjuvant Treatment in Participants With Stage IB - IIIB NSCLC With Uncommon Epidermal Growth Factor Receptor (EGFR) Mutations, Following Complete Surgical Resection With or Without Adjuvant Chemotherapy๏ผˆFIRMOST๏ผ‰
NCT07010419NSCLC, Adjuvant Treatment
Allist Pharmaceuticals, Inc.
Phase 3
338
Beijing, Guangdong
2025-05-28
Recruiting
Granzyme B-PET: Predicting Immunotherapy Efficacy in TNBC
NCT07705438Triple Negative Breast Cancer, Immune Checkpoint Inhibitor, Granzyme B PET/CT
Fudan University
Observational
30
Shanghai
2025-05-28
Not yet open
Deep Cervical Lymphaticovenous Anastomosis Surgery for Moderate-to-Advanced Dementia Patients
NCT06978946Alzheimer Disease, Lewy Body Dementia (LBD), Frontotemporal Dementia (FTD), Dementia
RenJi Hospital
Not applicable
85
Shanghai
2025-05-28
Recruiting
HW071021 Monotherapy in Patients With Advanced Solid Tumors
NCT06882135Advanced Solid Tumors
Wuhan Humanwell Innovative Drug Research and Development Center Limited Company
Phase 1
76
Guangzhou
2025-05-28
Recruiting
Near-Infrared Light Therapy Combined With Lecanemab for Mild Alzheimer's Disease
NCT06992804Alzheimer Disease
Xuanwu Hospital, Beijing
Phase EARLY_PHASE1
20
Beijing
2025-05-28
Recruiting
Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)
NCT06780098Lung Neoplasm
Merck Sharp & Dohme LLC
Phase 2
144
Beijing, Chongqing, Fuzhou, Nanning, Zhengzhou, Nanjing, Shanghai
2025-05-28
Recruiting
Fluzoparib+Bevacizumab/Dietary Intervention vs Fluzoparib Monotherapy as First-line Maintenance in HRD+/- Advanced Ovarian Cancer
NCT06954584Ovarian Cancer
Tongji Hospital
Phase 3
424
Wuhan
2025-05-27
Recruiting
Study in Patients With Advanced Solid Tumors to Evaluate the Safety of FTL008.16
NCT06410131Solid Tumors
Sound Biopharmaceuticals Ltd.
Phase 1
68
Beijing
2025-05-27
Recruiting
Phase II Trial of Tunlametinib in NRAS-Mutant Advanced Thyroid Cancer
NCT06970353Radioactive Iodine-refractory, Differentiated Thyroid Cancer With NRAS Mutation, Advanced PDTC or ATC With NRAS Mutation
Fudan University
Phase 2
40
Shanghai
2025-05-27
Active, closed
Phase I Clinical Trial of Lyophilized Herpes Zoster mRNA Vaccine in Adults Aged 40 Years or Above
NCT07285265Varicella-zoster Virus
Suzhou Abogen Biosciences Co., Ltd.
Phase 1
180
Liuzhou
2025-05-27
Recruiting
In Vivo Study on the Material Properties of iRoot SP and nRoot SP Root Canal Sealers
NCT07388901Chronic Apical Periodontitis
The Dental Hospital of Zhejiang University School of Medicine
Not applicable
160
Hangzhou
2025-05-27
Recruiting
Evaluating the Safety and Tolerability of Orally Administered DF-003 in ROSAH Syndrome Patients
NCT06395285ROSAH
Shanghai Yao Yuan Biotechnology Ltd. (also known as Drug Farm)
Phase 1
12
Beijing
2025-05-27
Recruiting
Safety and Efficacy Evaluation of GC101 Gene Therapy Via Intrathecal (IT) Injectionin the Treatment of Patients With Type 2 Spinal Muscular Atrophy (SMA) - Phase III
NCT06971094SMA - Spinal Muscular Atrophy
GeneCradle Inc
Phase 3
50
Beijing, Shanghai, Shenzhen, Suzhou, Wuhan
2025-05-27
Active, closed
Phase I Clinical Trial of Lyophilized Respiratory Syncytial Virus mRNA Vaccine in Adults Aged 18 Years or Above
NCT07289503Respiratory Syncytial Virus
Suzhou Abogen Biosciences Co., Ltd.
Phase 1
96
Baise City
2025-05-27
Active, closed
SMCs With LVH Compared to HCM
NCT07006974Syndromic and Metabolic Cardiomyopathy, Cardiomyopathies
China National Center for Cardiovascular Diseases
Observational
165
Beijing
2025-05-27
Active, closed
A Study of Switching to Picankibart in Chinese Patients With Plaque Psoriasis With an Inadequate Response to Interleukin-17 Monoclonal Antibody Therapy
NCT06945107Plaque Psoriasis
Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.
Phase 3
308
Jinan
2025-05-27
Recruiting
Construction of a Deep Learning-Based Precise Diagnostic Framework for Bladder Tumors Using Ultrasound: A Multicenter, Ambispective Cohort Study
NCT07111364Deep Learning, Ultrasound, Bladder Cancer
Peking University First Hospital
Observational
400
Beijing
2025-05-27
Recruiting
AK112 and Chemotherapy in First-line Metastatic Colorectal Cancer
NCT06951503Colorectal Adenocarcinoma
Akeso
Phase 3
560
Guanzhou
2025-05-27
Recruiting
Implementation of Machine Learning and Hemodynamic Profiles Based Clinical Decision Support Systems for Personalized Guideline Accordant Antihypertensive Regimens in Primary Care: a Pragmatic Cluster Randomized Controlled Trial
NCT06828692Hypertension
China National Center for Cardiovascular Diseases
Not applicable
2,160
Shenzhen
2025-05-26
Recruiting
A Phase Ib/II Clinical Study Evaluating the Safety and Efficacy of Tislelizumab in Combination With Golidocitinib and Selinexor for the Treatment of R/R NKTCL
NCT06966154Natural Killer/T-cell Lymphoma, Relapsed or Refractory Lymphoma Including ENKL
Fudan University
Phase 1/2
68
Shanghai
2025-05-26
Recruiting
Investigating Multigene Methylation Dynamics in Treatment Response Surveillance for Esophageal Carcinoma
NCT06979869Esophageal Cancer
Xijing Hospital
Observational
300
Wuwei, Shantou, Zhaoqing, Zhengzhou, Xi'an, Yanโ€™an, Taiyuan, Chengdu
2025-05-26
Active, closed
Intelligent Accelerated MRI for Pediatric Abdominal Pain
NCT07164651Pediatric Abdominal Pain
Yaqi Shen๏ผŒMD๏ผŒPhD
Observational
150
Wuhan
2025-05-26
Active, closed
A Study to Assess Safety and Effectiveness of HArmonyCa Lidocaine Injectable Gel for Restoration and/or Creation of Mid-Face Volume in Adult Participants
NCT07032597Mid Face Volume Deficit
AbbVie
Phase 3
252
Beijing, Wuhan, Nanjing, Wuxi, Shanghai, Hangzhou
2025-05-26
Recruiting
A Study of mRNA Encoding CD19/CD3 T Cell Engager (ABO2203) in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (B-NHL)
NCT07072169B-cell Non-Hodgkin Lymphoma
Ruijin Hospital
Phase 1
56
Shanghai
2025-05-26
Recruiting
Investigating Multigene Methylation Dynamics in Treatment Response Surveillance for Gastric Cancer
NCT06979895Gastric (Stomach) Cancer
Xijing Hospital
Observational
150
Xi'an
2025-05-26
Recruiting
A Phase Ib/II Clinical Study of Regorafenib Combined With Toripalimab and Albumin-bound Paclitaxel for the Third-line Treatment of Advanced Pancreatic Cancer
NCT07040228Pancreatic Cancer Metastatic
Junjie Hang
Phase 1/2
23
Shenzhen
2025-05-26
Recruiting
Treatment of Moyamoya Disease With iPSC-derived Exosomes
NCT07065409Moyamoya Disease
Huaqiu Zhang
Phase 1
9
Wuhan
2025-05-26
Recruiting
A Phase IIa Clinical Study to Assess the Efficacy and Safety of GenSci048 in Patients With Moderate to Severe Endometriosis-Associated Pain
NCT06963177Endometriosis-related Pain
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 2
200
Beijing
2025-05-26
Recruiting
A Clinical Trial on the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of TQB3019 Capsule in Subjects With Advanced Malignant Tumors
NCT06943677Advanced Malignant Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1
80
Beijing, Guangzhou, Zhengzhou, Nanjing, Nanchang, Xi'an, Heze, Jinan
2025-05-26
Recruiting
A Study on the Correlation Between Oral Health and Delirium in Surgical Inpatients
NCT06969092Oral Health
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Observational
550
Shanghai
2025-05-25
Not yet open
Ivonescimab in Combination With Liposomal Irinotecan and 5-FU/LV in Potentially Resectable Biliary Tract Malignancies
NCT06993025Biliary Tract Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 2
30
Tianjin
2025-05-25
Recruiting
Dual-target BCMA-CD19 CAR-T Cell Therapy for RR/MM With Extramedullary Infiltration
NCT07003555Relapsed or Refractory Multiple Myeloma (RRMM)
Beijing GoBroad Hospital
Phase 1
18
Shanghai
2025-05-25
Not yet open
Investigating Multigene Methylation Dynamics in Treatment Response Surveillance for Intestinal Carcinoma
NCT06979882Intestinal Cancer
Xijing Hospital
Observational
200
Xi'an
2025-05-25
By invitation
Mass Spectrometry-based Immune Profiling in Autoimmune Diseases
NCT07188285Systemic Lupus Erthematosus, Sjogren's Syndrome, Inflammatory Myopathies, Systemic Sclerosis (SSc)
Peking University People's Hospital
Observational
500
Beijing
2025-05-25
Recruiting
Dual-target BCMA-GPRC5D CAR-T Cell Therapy for RR/MM With Extramedullary Infiltration
NCT07003568Relapsed or Refractory Multiple Myeloma (RRMM)
Beijing GoBroad Hospital
Phase 1
18
Shanghai
2025-05-25
Recruiting
Phase I-II Clinical Study of Taurine for External Use in the Prevention and Treatment of Acute Radiation Skin Injury
NCT06847555To Evaluate the Safety of Taurine in Preventing Acute Radiation Skin Injury Induced by Adjuvant Radiotherapy in Breast Cancer Patients
Shandong Cancer Hospital and Institute
Phase 1/2
24
Jinan
2025-05-25
Recruiting
Tuvonralimab and Iparomlimab Based Regimens for the Neoadjuvant Treatment of Biliary Tract Cancer
NCT07267078Biliary Tract Cancer
Peking Union Medical College Hospital
Phase 2
45
Beijing
2025-05-25
Recruiting
A Randomized Controlled Trial of Gabor-Based Perceptual Learning for Adult Amblyopia
NCT07764198Amblyopia, Anisometropia
Jiannan Huang
Not applicable
80
Shanghai
2025-05-25
Recruiting
Tubeless Anesthesia in Preventing Lung Complications in Patients Undergoing Surgery for Early-Stage Lung Cancer
NCT07024433Lung Cancer Patients
Fujian Medical University Union Hospital
Not applicable
224
Fuzhou
2025-05-25
Recruiting
Different Models of Tracheal Catheters Are Used for Female Thyroid Glands
NCT06967896Sore Throat, Tracheal Tubes With an Inner Diameter of 6.0mm, Tracheal Tubes With an Inner Diameter of 6.5mm, Tracheal Tubes With an Inner Diameter of 7.0mm
Anqing Municipal Hospital
Observational
180
Anqing
2025-05-25
Not yet open
Study on the Mechanism of Multi-group Analysis of the Influence of Depression on Common Cardiovascular Diseases
NCT06975592Depression and CVD
First Affiliated Hospital of Harbin Medical University
Observational
300
Harbin
2025-05-25
Not yet open
Investigation Into the Safety and Efficacy of ICG-Labeled Fluorescence Imaging Technology in Guiding the Resection of Bone and Soft Tissue Tumors
NCT06979115Bone Neoplasms, Soft Tissue Neoplasms
Guangdong Provincial People's Hospital
Observational
40
Guangzhou
2025-05-25
By invitation
Efficacy and Safety of DS8201 in Metastatic Breast Cancer's Treatment
NCT06914661Breast Cancer Metastatic, Efficacy and Safety
The First Hospital of Jilin University
Observational
200
Changchun
2025-05-25
Recruiting
The Impact of Ultrasound-Guided Superficial and Deep Paravertebral Nerve Blocks at the Superior Costotransverse Ligament on Hemodynamics During the Induction Phase of Thoracoscopic Lung Lobectomy: A Multicenter, Double-Blind, Randomized Controlled Trial
NCT06841822Thoracic Paravertebral Block, Anesthesia Induction, Hypotension on Induction
Nanjing First Hospital, Nanjing Medical University
Not applicable
168
Nanjing
2025-05-25
Active, closed
A Study for the Evaluation of Efficacy and Safety of Proliaยฎ in Participants With Glucocorticoid-induced Osteoporosis in Mainland China
NCT06588153Glucocorticoid-induced Osteoporosis
Amgen
Phase 4
102
Beijing, Guangzhou, Shenzhen, Luoyang, Wuhan, Changzhou, Huaian, Nantong
2025-05-24
Recruiting
Electronic Symptom Monitoring of Patient-Reported Outcomes Among Patients With Hepatocellular Carcinoma During Immunotherapy (PRIME-HCC): Protocol for a Randomised Controlled Trial
NCT06938945Hepatocellular Carcinoma (HCC)
Wei Xiaoping
Not applicable
500
Haidian
2025-05-24
Recruiting
Study of ZG005 Combined With Gecacitinib in Patients With Advanced Non-Small Cell Lung Cancer
NCT06903377Non-small Cell Lung Cancer
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Phase 1/2
50
Shanghai
2025-05-23
Recruiting
Boron Neutron Capture Therapy With B10 L-BPA for Unresectable Recurrent Head and Neck Cancers
NCT06952868Head and Neck Cancer, Boron Neutron Capture Therapy
China Medical University Hospital
Phase 2
24
2025-05-23
Recruiting
A Clinical Trial of Rabies Vaccine๏ผˆHuman Diploid Cell๏ผ‰for Human Use,Freeze-dried
NCT07021703Rabies
Ningbo Rongan Biological Pharmaceutical Co., Ltd.
Phase 1
60
Zhengzhou
2025-05-23
By invitation
XS-03 in Combination With FOLFOX or FOLFIRI and Bevacizumab for Treatment of Metastatic Colorectal Cancer Patients With RAS Mutation
NCT06936527Colorectal Cancer, Metastatic Colorectal Cancer With RAS Mutation
NovaOnco Therapeutics Co., Ltd.
Phase 1/2
102
Beijing
2025-05-23
Recruiting
GemCis Plus PD-1/PD-L1 Inhibitor in Advanced Biliary Tract Cancer: Efficacy and Immune Microenvironment ๏ผˆBTC-IM-1๏ผ‰
NCT06988592Advanced Biliary Tract Cancer
Fudan University
Observational
100
Shanghai
2025-05-23
Recruiting
A Phase I Clinical Trial to Evaluate the Single Dose Ascending and Food Effects of PG-033 in Healthy Adults
NCT07013097Lichen Simplex Chronicus
Prime Gene Therapeutics Co., Ltd.
Phase 1
52
Beijing
2025-05-23
Recruiting
Precision Antiplatelet Therapy Guided by Platelet Aggregation Function in Patients With Acute Ischemic STROKE
NCT06853535Acute Ischemic Stroke, Clopidogrel Resistance
Sichuan Provincial People's Hospital
Phase 3
5,138
Chengdu
2025-05-23
Recruiting
The CD19/CD20 Dual-Target in Vivo CAR-T Lentiviral Product in the Treatment of Relapsed/Refractory B-cell Malignancies
NCT07002112Relapsed/Refractory B-cell Malignancies
The First Affiliated Hospital with Nanjing Medical University
Phase 1
30
Hefei, Beijing, Shijiazhuang, Zhengzhou, Wuhan, Nanjing
2025-05-23
Recruiting
A Clinical Study of HRS-6209 Combined With Other Treatment Regimens in Patients With Breast Cancer
NCT06974929Breast Cancer
Jiangsu HengRui Medicine Co., Ltd.
Phase 1/2
80
Tianjin
2025-05-22
Recruiting
Efficacy and Safety of Sanggua Tablets in the Treatment of Patients With Impaired Glucose Tolerance and Mild Type 2 Diabetes
NCT06964620Diabetes Mellitus, Type 2, Impaired Glucose Tolerance
Tongji Hospital
Phase EARLY_PHASE1
84
Wuhan
2025-05-22
Recruiting
Photoacoustic/Ultrasound Imaging of Brown Adipose Tissue Activity
NCT07327684Insulin Resistance, Metabolic Syndrome
Peking Union Medical College Hospital
Not applicable
100
Beijing
2025-05-22
Recruiting
A Clinical Study to Evaluate the Safety and Efficacy of CLL1 and CD38 Dual-Target CAR-T Cell Injection in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
NCT06880354Acute Myeloid Leukemia
Institute of Hematology & Blood Diseases Hospital, China
Phase 1
37
Tianjin
2025-05-22
Active, closed
A Study for HSK44459 in Participants With Atopic Dermatitis
NCT06996912Atopic Dermatitis (AD)
Xizang Haisco Pharmaceutical Co., Ltd
Phase 2
150
Jinan
2025-05-22
Recruiting
A Prospective, Open-label, Single-arm, Exploratory Clinical Trial to Evaluate the Safety and Tolerability of 225Ac-TR2205 Injection in Patients With Triple-negative Breast Cancer.
NCT07340424Advanced Metastatic Triple-negative Breast Cancer (mTNBC)
Xiaorong Sun
Phase EARLY_PHASE1
15
Jinan
2025-05-22
Recruiting
Personalized Timing of Interval Debulking Surgery in Advanced Ovarian Cancer
NCT07023484Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma
The University of Hong Kong
Phase 2
126
Guangzhou, Shenzhen
2025-05-22
Recruiting
Human Umbilical Cord Mesenchymal Stem Cells Treatment in Sepsis
NCT06882811Sepsis
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Phase EARLY_PHASE1
180
Chongqing
2025-05-22
Recruiting
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
NCT06952504Endometrial Cancer
Merck Sharp & Dohme LLC
Phase 3
1,123
Hefei, Beijing, Chongqing, Fuzhou, Xiamen, Guangzhou, Shantou, Zhanjiang
2025-05-22
Recruiting
An Open-label, Phase I Clinical Trial of Super1 TCR-T in NY-ESO-1-positive Patients With Advanced Solid Tumors
NCT06942143Sarcoma, Lung Cancers, Melanoma
Guangzhou FineImmune Biotechnology Co., LTD.
Phase 1
15
Guangzhou
2025-05-22
Active, closed
A Phase 2 Study of D-2570 in Subjects With Moderately to Severely Active Ulcerative Colitis
NCT07035041UC - Ulcerative Colitis, Moderately to Severely Active Ulcerative Colitis
InventisBio Co., Ltd
Phase 2
120
Hangzhou
2025-05-22
Recruiting
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
NCT06901531Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
Astellas Pharma Global Development, Inc.
Phase 3
500
Hefei, Fuzhou, Guangzhou, Harbin, Zhenngzhou, Wuhan, Xining, Shanghai
2025-05-22
Recruiting
Reduced Dose Radiotherapy vs Standard Dose Radiotherapy for Early Stage Nasopharyngeal Carcinoma
NCT06912698Nasopharyngeal Cancinoma (NPC)
Hai-Qiang Mai,MD,PhD
Phase 3
342
Guangzhou
2025-05-22
Recruiting
Individualized Comprehensive Treatment for Advanced Hepatocellular Carcinoma
NCT06893887Hepatocellular Carcinoma(HCC)
Nanjing Tianyinshan Hospital
Not applicable
300
Nanjing
2025-05-22
Recruiting
Liraglutide Treatment in Obese Infertile PCOS Women
NCT06742710PCOS, Obesity, Infertility
Peking University Third Hospital
Phase 4
890
Beijing
2025-05-22
By invitation
The Efficacy and Safety of IBI351, Cetuximab ฮฒ Combined With FOLFIRI as First-line /IBI351, Cetuximab ฮฒ as Second-line in the Treatment of KRAS G12C-mutated Metastatic Colorectal Cancer
NCT06959589Colorectal Cancer Metastatic, KRAS G12C Mutation
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
50
Hangzhou
2025-05-22
Recruiting
Romiplostim N01 Combined With Glucocorticoids as the First-line Treatment for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Multicenter, Interventional Trial
NCT06992128Primary Immune Thrombocytopenia (ITP)
Institute of Hematology & Blood Diseases Hospital, China
Phase 2
129
Tianjin
2025-05-22
Recruiting
A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN)
NCT06962800Primary Membranous Nephropathy
Biogen
Phase 3
180
Fuyang, Beijing, Xichengqu Beijing, Xiamen, Lanzhou, Guangzhou, Shenzhen, Nanning
2025-05-22
Recruiting
Construction and Clinical Application of the Immune Map of Pancreatic Cancer Evolution
NCT07034339Immune Evasion, Tumor, Pancreas Cancer
First Affiliated Hospital of Zhejiang University
Observational
1,500
Hangzhou
2025-05-21
Recruiting
Reduced ATG Plus Mini PTCy for GVHD Prophylaxis in Haplo-SCT
NCT06984536Myelodysplastic Syndrome, Acute Leukemia
Peking University People's Hospital
Phase 2
40
Beijing
2025-05-21
Recruiting
Teclistamab in Previously Treated AL Amyloidosis
NCT06935162AL Amyloidosis
Peking Union Medical College Hospital
Phase 2
30
Beijing
2025-05-21
Recruiting
AK129 Combination Therapy for Advanced Solid Tumors
NCT06943820Non-small Cell Lung Cancer Stage IIIB/IV, Head and Neck Squamous Cell Carcinoma (HNSCC), Colorectal Adenocarcinoma, Advanced Solid Tumors
Akeso
Phase 1/2
230
Shenyang
2025-05-21
Recruiting
Safety, Pharmacokinetics and Preliminary Efficacy of CS231295 in Advanced Solid Tumors
NCT06902350Neoplasms, Glioblastoma, Adult, Small Cell Lung Carcinoma (SCLC)
Chipscreen Biosciences, Ltd.
Phase 1
102
Beijing, Changchun
2025-05-21
Recruiting
Comparison of the Diagnostic Performance of Different Artificial Intelligence Assisted Endocytoscopy for Colorectal Lesions
NCT06982872Endocytoscopy
The First Hospital of Jilin University
Observational
500
Changchun
2025-05-21
Rows per page Showing 7901–8000 of 19052
Previous 78 79 80 81 82 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 22 September 2026. https://priyalifescience.com/clinical-trials-china?page=80

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.